What to know about injectable lenacapavir for HIV prevention
Discover how twice‑yearly injectable lenacapavir works for HIV prevention, why WHO and FDA support it, and what it means for equity and access.
Read More...By James Calder on July 21, 2025
Discover how twice‑yearly injectable lenacapavir works for HIV prevention, why WHO and FDA support it, and what it means for equity and access.
Read More...By James Calder on July 21, 2025
Explore how U.S. federal funding cuts are disrupting HIV research, prevention, and testing—examining domestic and global ripple effects.
Read More...By James Calder on July 15, 2025
Explore the latest breakthroughs in HIV studies—from vaccine development to social determinants of health—with clear insights and expert viewpoints.
Read More...By James Calder on July 14, 2025
Discover modern HIV prevention methods including condoms, PrEP, PEP, TasP, long-acting injectables, and innovative multipurpose technologies—all designed to empower individuals and communities in 2025.
Read More...By James Calder on July 14, 2025
Discover how HIV support groups provide crucial emotional, educational, and medical benefits—including peer connection, treatment adherence, and stigma reduction—for people living with HIV.
Read More...
|
© 2025 Aids.org